|
市場調査レポート
商品コード
1184273
血管閉鎖装置の世界市場規模、シェア、産業動向分析レポート:用途別(腹腔鏡手術、一般外科)、最終用途別、製品別(器具、ジェネレータ、アクセサリー)、地域別展望と予測、2022年~2028年Global Vessel Sealing Devices Market Size, Share & Industry Trends Analysis Report By Application (Laparoscopic Surgery and General Surgery), By End Use, By Product (Instruments, Generators and Accessories), By Regional Outlook and Forecast, 2022 - 2028 |
||||||
血管閉鎖装置の世界市場規模、シェア、産業動向分析レポート:用途別(腹腔鏡手術、一般外科)、最終用途別、製品別(器具、ジェネレータ、アクセサリー)、地域別展望と予測、2022年~2028年 |
出版日: 2022年12月30日
発行: KBV Research
ページ情報: 英文 186 Pages
納期: 即納可能
|
血管閉鎖装置の世界市場規模は、2028年までに26億米ドルに達し、予測期間中にCAGR9.7%の市場成長率で上昇すると予測されています。
従来のモノポーラ・デバイスは、横方向の熱の広がりが大きく、不確実で弱い血管封鎖が行われていました。現代の外科診療で最も頻繁に採用されている止血エネルギーデバイスは、バイポーラ式と超音波式の2種類です。
現代のバイポーラデバイスは、デバイスの爪から電流が広がるのを止め、血管を密閉し、電気熱エネルギーで周囲の組織へのダメージを最小限に抑えます。一方、超音波装置は電流ではなく高周波の振動を利用しますが、そのエネルギーは装置のジョーの間で非常に薄くしか伝わらないのです。
COVID-19の影響分析
このような状況下、医療機関では移動規制が実施され、学会や規制当局から待機手術の延期勧告が出され、大多数の国が封鎖状態に陥りました。このため、血管シール装置の需要は減少しました。COVID-19の流行が回復期に入ると、腹腔鏡下手術は通常の状態に戻ると予想されます。また、COVID-19の大流行により、腹腔鏡機器の使い捨てが促進されました。腹腔鏡下手術は使い捨てであるため、交差汚染が起こりにくく、パンデミックの期間中も使用できるメリットがあります。その結果、血管閉鎖装置の市場はパンデミック以降、急速に回復しています。
市場の成長要因
世界市場を牽引する新技術
低侵襲性血管閉鎖装置の需要は、婦人科、泌尿器科、心臓病学、整形外科、一般外科のニーズの高まりに後押しされています。新しいソフトウェアと洗練された血管閉鎖装置の開発により、連続的な血管閉鎖装置のワークフローが実現し、外科医は迅速で正確、かつ痛みのない手術を効率的に行えるようになりました。
低侵襲手術への関心の高まり
従来の開腹手術に比べ、低侵襲手術は恐怖感が少ないのが特徴です。従来の腹腔鏡下手術では、手術が難しく、苦痛を伴うことがありました。この手術では、専用の小型機器と低侵襲の腹腔鏡カメラを使用し、小さな切開部から挿入します。低侵襲手術の後、患者はより早く、より少ない痛みで回復することができます。低侵襲手術の普及に伴い、血管シールデバイスの市場は拡大する可能性があります。
市場阻害要因
血管閉鎖装置の問題点
血管内封止装置には多くの利点があるが、いくつかの欠点が業界の拡大を阻む可能性があります。血管シーリング法は、横方向の熱エネルギー分布の結果、神経、尿管、腸を損傷する可能性があります。この横方向のエネルギー分散により、2mmの組織が損傷します。大山昇三郎は2020年のエッセイで、LigaSureは手術の難しさにつながる可能性があると述べています。厚く密な組織が刃の間に収まらないため、LigaSureは重要な血管や神経を挟み込むことができないのです。また、血管シール装置の問題もあり、事業の妨げになることが予想されます。
アプリケーションの展望
血管固定装置市場は、用途別に腹腔鏡下手術と一般外科に分けられます。2021年の血管閉鎖装置市場では、一般外科が大きな収益シェアを占めています。これは、S状結腸切除術や盲腸切除術などの手術で頻繁に選ばれていることに起因します。このような好みは、腹腔鏡手術よりもこれらの処置の成功率が優れていることで説明されるかもしれません。一般的な手術は、価格が高く、術後の入院期間が長いため、市場シェアは小さいです。
製品の展望
血管閉鎖装置市場は、製品によってジェネレーター、インスツルメント、アクセサリーに分類されます。2021年、ジェネレーター市場セグメントは、血管シーリング産業における重要な収益シェアを示しました。バイポーラ治療と血管シーリング治療は、血管シーリング発電機とも呼ばれる電気外科用発電機で駆動されます。エネルギーデバイスは、血管シーリングや剥離のための低侵襲手術でますます使用されています。これらの発電機は、血管内腔の完全かつ長期的な融合を達成するために、あらかじめ定義された期間、血管に正確なエネルギーと電極の圧力を与えます。
最終用途の展望
血管閉鎖装置の市場は、エンドユーザーに基づき、外来手術センター、病院、専門クリニックに区分されます。2021年の血管閉鎖装置市場は、病院セクターの収益シェアが最大となっています。これは、より多くの処置が病院で実施されるようになった結果です。特に再利用可能な血管シーリングシステムは、エンドユーザーに高い効果とコスト削減を提供します。使い捨てのデバイスと比較して、修正頸部全切除手術で使用される再利用可能な血管閉鎖装置は、医療費を劇的に削減することができます。
地域別の展望
血管閉鎖装置市場は、地域別に、北米、欧州、アジア太平洋、LAMEAに分類されます。2021年には、北米地域が血管閉鎖装置市場を独占しました。米国とカナダには、最先端技術を持つ重要な企業や病院が存在することが、この地域のかなりの市場シェアを占めています。さらに、米国では、悪い食習慣、すぐに用意できるスナックへの欲求、運動不足、ストレスの多いライフスタイル、相当数の高齢者人口の結果として、慢性医療障害の有病率が上昇しており、市場の拡大を促しています。
List of Figures
The Global Vessel Sealing Devices Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 9.7% CAGR during the forecast period.
By totally occluding the blood vessel and denaturing the collagen and elastin in the vessel wall, vessel sealing devices are utilized to seal the vessel wall. The most popular energy-based surgical instruments include hybrid, ultrasonic, and bipolar.
In both open and laparoscopic operations, energy-based vascular sealing devices (VSDs) have been created to speed up dissection and hemostasis. With less blood loss and shorter operating periods, these technologies allow surgeons to increase the effectiveness and safety of surgeries. In modern medicine, there is a constant demand for technological advancement to manufacture high-quality VSDs with more accurate vascular sealing quality and less heat harm to surrounding tissues.
Traditional monopolar devices have increased lateral heat spread and uncertain, weak vessel sealing. The two types of hemostatic energy devices that are most frequently employed in modern surgical practice are bipolar and ultrasonic ones.
Modern bipolar devices stop electric current from spreading through the device's jaws, sealing blood vessels and minimizing damage to the tissues around them with electrothermal energy. In contrast, ultrasonic devices use high-frequency vibrations rather than electrical current, but the energy can only be transmitted very thinly between the device's jaws.
COVID-19 Impact Analysis
Movement restrictions were implemented, and the majority of countries went into lockdown as academic societies and regulatory authorities advised delaying elective surgical procedures. All of this led to a decline in the demand for vessel sealing devices. It is anticipated that laparoscopic device procedures would return to normal as the COVID-19 pandemic's recovery phase gets underway. Additionally, the COVID-19 pandemic promoted the use of disposable laparoscopic instruments. Cross-contamination is prevented by single-use laparoscopic instruments, which proved to be an advantageous circumstance for their use throughout the COVID-19 pandemic. As a result, the market for vessel sealing devices has quickly recovered since the pandemic.
Market Growth Factors
New Technologies To Drive The Global Market
The demand for minimally invasive vessel sealing devices has been driven by the rise in gynecological, urological, cardiology, orthopedic, and general surgery needs. A continuous vessel-sealing device workflow is delivered through the development of new software and sophisticated vessel-sealing devices, allowing the surgeon to do quick, accurate, painless surgeries with increased efficiency.
Rising Interest In Minimally Invasive Procedures
Compared to traditional open surgeries, minimally invasive surgeries are significantly less frightening. Traditional procedures carried out using standard laparoscopic tools can be difficult and distressing. The procedure is carried out with the assistance of specialized, smaller equipment and minimally invasive laparoscopic cameras that are placed through smaller incisions. After minimally invasive operations, patients can recover more quickly and with less pain. The market for vessel sealing devices may expand as minimally invasive operations become more popular.
Market Restraining Factors
Problems With Using Vessel Sealing Devices
Despite the many advantages of vessel sealing systems, some disadvantages can prevent the industry from expanding. Vessel sealing methods can damage nerves, ureters, and bowels as a result of lateral thermal energy distribution. 2 mm of tissue is damaged by this lateral energy dispersion. In a 2020 essay, Shosaburo Oyama said that LigaSure could lead to surgical difficulties. Due to the inability of thick, dense tissues to fit between blades, LigaSure is unable to clamp vital blood vessels and nerves. It is anticipated that issues with vessel sealing devices may hinder the business.
Application Outlook
On the basis of Application, the Vessel Sealing Devices Market is divided into Laparoscopic Surgery and General Surgery. In the market for vessel sealing devices in 2021, the general surgery sector accounted for a sizeable revenue share. This is due to the fact that it is frequently chosen in procedures like sigmoidectomies and appendectomies. This preference may be explained by the superior success rate of these procedures over laparoscopy. General procedures have a small market share due to their high price and extended post-operative hospital stay.
Product Outlook
Based on the product, the vessel sealing devices market is divided classified into generators, instruments, and accessories. In 2021, the generators market segment showcased the significant revenue share in the vessel sealing industry. Bipolar and vessel sealing treatments are powered by electrosurgical generators, also referred to as vessel sealing generators. Energy devices are increasingly used in minimally invasive surgery for vessel sealing and dissection. These generators give accurate energy and electrode pressure to vessels for a predefined period of time in order to accomplish a full and long-lasting fusion of the vessel lumen.
End-use Outlook
Based on End-use, the market for vessel sealing devices is segmented into ambulatory surgery centers, hospitals, and specialized clinics. The market for vessel sealing devices in 2021 saw the biggest revenue share in the hospital sector. This is a result of more procedures being carried out in hospital settings. Reusable vessel sealing systems, in particular, provide end users with greater effectiveness and cost savings. Compared to disposable devices, reusable vascular sealing devices used during modified total neck dissection operations can dramatically lower medical expenses.
Regional Outlook
By geography, the vessel sealing devices market is categorized into North America, Europe, Asia Pacific, and LAMEA. In 2021, the North American region dominated the vessel sealing devices market. The presence of significant firms and hospitals with cutting-edge technology in the United States and Canada accounts for the region's considerable market share. Additionally, the rising prevalence of chronic medical disorders in the US as a result of bad eating habits, a desire for quick-to-prepare snacks, a lack of exercise, a stressful lifestyle, and a sizable older population is encouraging market expansion.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, B. Braun Melsungen AG, Johnson & Johnson, Intuitive Surgical, Inc., Hologic, Inc. (Bolder Surgical), Erbe Elektromedizin GmbH, BOWA-electronic GmbH & Co. KG, OmniGuide, Inc., and KLS Martin Group.
Strategies deployed in Vessel Sealing Devices Market
Sep-2022: Olympus Corporation introduced THUNDERBEAT Open Fine Jaw Type X surgical energy devices to support safer procedures for open surgery. The product is designed to deliver ultrasonic and bipolar energy concurrently that allow genuine vessel division and sealing, speedy hemostatic cutting and easy dissection.
Jan-2022: Erbe Elektromedizin launched Biclamp Knife 220, a product designed to seal and cut vessels during surgical procedures and simplify the surgery. The product built with the capability to anatomize close to critical structures, seal vessels up to 7mm in diameter, manage diffuse bleedings of larger surface areas as well as stop inadvertent thermal effects to adjoining tissue as the temperature on the back of the jaws would be about below 40°C.
Nov-2021: Hologic, Inc. acquired Bolder Surgical to add dissecting devices, vessel sealing, and dividing to its surgical portfolio. With this acquisition, all the Bolder's devices would be added to the Hologic product offering including JustRight 3mm vessel sealer, JustRight 5mm stapler, and CoolSeal vessel sealing suite. Additionally, this would enhance the company's OB/GYN specialists.
Sep-2021: Olympus announced the launch of POWERSEAL, an Advanced Bipolar Surgical Energy single-use Devices. This launch strengthens the Surgical suite, the device is built with the feature of efficient and strong sealing of vessels, Minimal thermal spread with low exterior jaw temperature and Fast cool-down times, Multifunctional capabilities as well as dependability of 3x systolic blood pressure.
Jan-2021: Bolder Surgical introduced the CoolSeal Vessel Sealing platform, with an aim to enlarge the offering of vessel sealing products. The platform launch contains the CoolSeal generator, a 3mm CoolSeal Mini vessel sealer, and the CoolSeal Trinity, a new 5 mm laparoscopic vessel sealer surgical instrument used for urological, gynecological, and general surgery. CoolSeal Trinity contains 360-degree capability with dual-action jaws that allows quick sealing time and precise dissection along with the least thermal distribution surrounding major structures.
Jul-2020: BOWA Medical announced an agreement with Lexington Medical, a supplier of minimally-invasive surgical stapling solutions. Under the agreement, the LOTUS system, made by BOWA Medical, and AEON Endostapler, made by Lexington Medical would be marketed jointly by both companies globally. This would strengthen their best-in-class manufacturing and product leadership globally.
Dec-2019: Intuitive received FDA approval for SynchroSeal and E-100 generator that would be used in sealing procedures. SynchroSeal was a robotic system sealing instrument used to transect tissue whereas the E-100 generator provides power to SynchroSeal. The products were designed to empower surgeons to carry out transaction with a single pedal press and quick one-step sealing.
Apr-2018: Medtronic PLC launched LigaSure exact dissector, which offers two times faster cooling with precise dissection and superior access. The newly launch product is based on LigaSure™ vessel sealing technology, which makes it easy to seal and cut as well as, with its fine, curved jaw maximizes the line of sight.
Market Segments covered in the Report:
By Application
By End Use
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research